Slate Path Capital’s Corteva CTVA Stock Holding History

Slate Path Capital’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-110,000	Closed	-$3.25M	–	32
2019 Q2	$3.25M	Buy	+110,000	New	+$2.96M	0.15%	24

Other funds holding CTVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Slate Path Capital's CTVA Position: Q3 2019 in Review

Slate Path Capital sold out of Corteva (CTVA) in Q3 2019, closing a stake of 110,000 shares — an estimated $3.25M sold.

Slate Path Capital first reported a position in CTVA in Q2 2019 and held it in 1 quarter. The position peaked at $3.25M in Q2 2019. 983 funds tracked by Wall St. Rank hold CTVA as of Q3 2019.

Slate Path Capital reported no remaining Corteva position as of Q3 2019 after selling out during the quarter.
Slate Path Capital sold 110,000 Corteva shares in Q3 2019, an estimated $3.25M.
Slate Path Capital first reported a position in Corteva in Q2 2019 and held it in 1 quarter.
Slate Path Capital's Corteva position peaked at $3.25M in Q2 2019.
983 funds tracked by Wall St. Rank held Corteva as of Q3 2019.

Based on Slate Path Capital's 13F filing for Q3 2019, filed 14 Nov 2019.